Literature DB >> 35368364

Corticosteroids Should Be Used To Treat Slowly Progressive IgA Nephropathy: PRO.

Amanda M Cunningham1, Heather N Reich1.   

Abstract

Entities:  

Keywords:  IGA glomerulonephritis; IgA nephropathy; adrenal cortex hormones; corticosteroids; glomerular and tubulointerstitial diseases; glomerulonephritis; therapy; treatment

Mesh:

Substances:

Year:  2021        PMID: 35368364      PMCID: PMC8786088          DOI: 10.34067/KID.0007192020

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


× No keyword cloud information.
  16 in total

Review 1.  Corticosteroid therapy in IgA nephropathy.

Authors:  Jicheng Lv; Damin Xu; Vlado Perkovic; Xinxin Ma; David W Johnson; Mark Woodward; Adeera Levin; Hong Zhang; Haiyan Wang
Journal:  J Am Soc Nephrol       Date:  2012-04-26       Impact factor: 10.121

2.  Corticosteroids in IgA nephropathy: a randomised controlled trial.

Authors:  C Pozzi; P G Bolasco; G B Fogazzi; S Andrulli; P Altieri; C Ponticelli; F Locatelli
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

3.  After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.

Authors:  Thomas Rauen; Stephanie Wied; Christina Fitzner; Frank Eitner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Klemens Budde; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  Kidney Int       Date:  2020-05-22       Impact factor: 10.612

Review 4.  How does proteinuria cause progressive renal damage?

Authors:  Mauro Abbate; Carla Zoja; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 10.121

5.  Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.

Authors:  Sean J Barbour; Rosanna Coppo; Hong Zhang; Zhi-Hong Liu; Yusuke Suzuki; Keiichi Matsuzaki; Ritsuko Katafuchi; Lee Er; Gabriela Espino-Hernandez; S Joseph Kim; Heather N Reich; John Feehally; Daniel C Cattran
Journal:  JAMA Intern Med       Date:  2019-07-01       Impact factor: 21.873

6.  Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Authors:  Thomas Rauen; Frank Eitner; Christina Fitzner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

7.  Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Authors:  Jicheng Lv; Hong Zhang; Muh Geot Wong; Meg J Jardine; Michelle Hladunewich; Vivek Jha; Helen Monaghan; Minghui Zhao; Sean Barbour; Heather Reich; Daniel Cattran; Richard Glassock; Adeera Levin; David Wheeler; Mark Woodward; Laurent Billot; Tak Mao Chan; Zhi-Hong Liu; David W Johnson; Alan Cass; John Feehally; Jürgen Floege; Giuseppe Remuzzi; Yangfeng Wu; Rajiv Agarwal; Hai-Yan Wang; Vlado Perkovic
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272

8.  Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy.

Authors:  Minoru Kuriki; Koichi Asahi; Kenichiro Asano; Kaoru Sakurai; Masaaki Eiro; Hodaka Suzuki; Kazuo Watanabe; Tetsuo Katoh; Tsuyoshi Watanabe
Journal:  Nephrol Dial Transplant       Date:  2003-07       Impact factor: 5.992

9.  Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.

Authors:  Min Jeong Kim; Stefan Schaub; Karen Molyneux; Michael T Koller; Susanne Stampf; Jonathan Barratt
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

10.  NF-κB signaling in inflammation.

Authors:  Ting Liu; Lingyun Zhang; Donghyun Joo; Shao-Cong Sun
Journal:  Signal Transduct Target Ther       Date:  2017-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.